Additional information on COVID-19 vaccines and A-T can be found here.

Hi A-T Parents,

As promised, we are getting together for a discussion about COVID-19 and vaccines.

The A-T Children’s Project has planned a special webinar that I will be moderating:

COVID-19 Vaccines and Ataxia-Telangiectasia – a conversation with:

  • Howard Lederman, MD, PhD – Pediatric Immunologist and Director of the A-T Clinical Center at Johns Hopkins Children’s Center
  • Brad Margus – Founder of the A-T Children’s Project and father of two sons with A-T

Monday, January 11 at 8:00 PM Eastern (5:00 PM Pacific)

Watch the replay on our YouTube channel: https://www.youtube.com/watch?v=Pr8wVGFfWC8

The webinar will be recorded. Everyone who registers will receive a link to the recording whether or not you attend live.

Dr. Lederman will not be able to offer individual advice, but please do let me know if you have any general questions by emailing me at jennifer@atcp.org.

We hope this helps!

Keep safe,

Jennifer

Jennifer Thornton, Executive Director

Related News

Jan 24 @ 6:53 am

Press Release from Business Wire about A-T Trial Results

IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.

more
Jan 24 @ 6:53 am

Encouraging News from an A-T Clinical Trial

IntraBio announced positive results from its pivotal Phase III clinical trial of a drug for children and adults

more
Jan 24 @ 6:53 am

Heading into 2026 with big momentum for A-T

The A-TCP is excited about how much possibility this moment holds for A-T research.

more
Jan 24 @ 6:53 am

Breaking News about A-T and GRP94

A-TCP funds a researcher who sheds new light on A-T and on how the ATM gene functions in

more